The GLP is committed to full transparency. Download and review our Annual Report.

The GLP is committed to full transparency. Download and review our Annual Report.

Judge upholds landmark glyphosate-cancer verdict, cuts punitive damages 84% to $39 million

| | October 23, 2018

California judge has rejected Monsanto’s appeal to overturn a landmark jury verdict which found that its popular herbicide causes cancer.

The judge’s ruling on [October 22] largely sided with Dewayne “Lee” Johnson, a father of three and former school groundskeeper, who won a $289m award over the summer after alleging that his exposure to Roundup weedkiller gave him cancer. During the trial, the first of its kind, the 46-year-old also alleged that Monsanto had failed to warn him of the risks of using its product.

Monsanto fought to overturn the verdict, arguing the evidence was insufficient. The San Francisco superior court judge Suzanne Bolanos had suggested in an initial written ruling this month that she was considering granting a new trial. But she ultimately denied Monsanto’s request. However, she has ruled to reduce punitive damages from $250m to $39m.

Related article:  Lessons learned from the 2017 Monsanto dicamba herbicide fiasco

Thousands of plaintiffs across the country have made similar legal claims, alleging that glyphosate exposure caused their cancer or resulted in the deaths of their loved ones. Monsanto and Bayer have repeatedly insisted that glyphosate is safe to use and does not cause cancer.

Read full, original article: Monsanto trial: judge rejects bid to overturn landmark cancer verdict

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend